SCHEMBL25350771

SCHEMBL25350771

CN(C)CC(=O)Nc1cccc(-c2cn(Cc3ccc(-c4nnc(C(F)F)o4)cn3)nn2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 12/20 0.48
▸ AURKB Q96GD4 2/20 0.42
▸ STK17A Q9UEE5 1/20 0.42
▸ CDC7 O00311 1/20 0.42
▸ IKBKB O14920 1/20 0.42
▸ MAPK13 O15264 1/20 0.42
▸ DAPK3 O43293 1/20 0.42
▸ DYRK3 O43781 1/20 0.42
▸ ROCK2 O75116 1/20 0.42
▸ PRKD3 O94806 1/20 0.42
▸ CDK1 P06493 1/20 0.42
▸ PIM1 P11309 1/20 0.42
▸ PRKACA P17612 1/20 0.42
▸ CDK2 P24941 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ MAPK9 P45984 1/20 0.42
▸ CSNK1D P48730 1/20 0.42
▸ CDK8 P49336 1/20 0.42
▸ CLK2 P49760 1/20 0.42
▸ GSK3B P49841 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25351671 0.92 HDAC6 (0.47) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL25216547 0.90 HDAC6 (0.51) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL30424695 0.90 HDAC6 (0.51) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL25350185 0.89 HDAC6 (0.52) HDAC6AURKBSTK17ACDC7IKBKB
SCHEMBL25351958 0.89 HDAC6 (0.52) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL25350716 0.88 HDAC6 (0.47) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL25350996 0.88 HDAC6 (0.49) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL30410398 0.88 HDAC6 (0.49) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL24216211 0.87 HDAC6 (0.49) HDAC6GSK3BDYRK1AHDAC1HDAC3
SCHEMBL24216698 0.87 HDAC6 (0.49) HDAC6HDAC1HDAC3HDAC2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC6, HDAC1, HDAC3 HDAC6 1/4885AURKB 393/4885STK17A 677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback